Last updated on

Circulation. Cardiovascular quality and outcomes
Research Hotspot & Journal Scope - Cardiovascular


Circulation. Cardiovascular quality and outcomes - DOI: 10.1161/CIRCOUTCOMES.118.005404
Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular Outcomes

Kelly D Myers · Niloofar Farboodi · Mkaya Mwamburi · William Howard · David Staszak · Samuel Gidding · Seth J Baum · Katherine Wilemon · Daniel J Rader ·

Medicine
PDF
Circulation. Cardiovascular quality and outcomes - DOI: 10.1161/CIRCOUTCOMES.118.005342
Dog Ownership and Survival After a Major Cardiovascular Event: A Register-Based Prospective Study.

Mwenya Mubanga · Liisa Byberg · Agneta Egenvall · Erik Ingelsson · Tove Fall ·

Medicine
PDF
Circulation. Cardiovascular quality and outcomes - DOI: 10.1161/CIRCOUTCOMES.118.005438
Cardiologist Participation in Accountable Care Organizations and Changes in Spending and Quality for Medicare Patients With Cardiovascular Disease.

Devraj Sukul · Andrew M Ryan · Phyllis Yan · Adam Markovitz · Brahmajee K Nallamothu · Valerie A Lewis · John M Hollingsworth ·

Medicine
PDF
Circulation. Cardiovascular quality and outcomes - DOI: 10.1161/CIRCOUTCOMES.118.005420
Integrating Quality of Life and Survival Outcomes Cardiovascular Clinical Trials.

Jacob V Spertus · Laura A Hatfield · David J Cohen · Suzanne V Arnold · Martin Ho · Philip G Jones · Martin Leon · Bram Zuckerman · John A Spertus ·

Medicine
PDF
Circulation. Cardiovascular quality and outcomes - DOI: 10.1161/CIRCOUTCOMES.119.005563
Increased Cardiovascular Disease Risk in Veterans With Mental Illness.

Mary C Vance · Wyndy L Wiitala · Jeremy B Sussman · Paul Pfeiffer · Rodney A Hayward ·

Medicine
PDF

Articles published up to August 1, 2019 in the field of AI and ML in cardiovascular medicine are also reviewed and placed in the context of the potential role these approaches will have in clinical practice in the future.

Artificial Intelligence and Machine Learning in Cardiovascular Healthcare. [10.1016/j.athoracsur.2019.09.042]


The mechanisms and mediators of this phenomenon have not been fully explained, but an expanding body of evidence demonstrates that increased cardiovascular risk in AS is heralded by endothelial dysfunction.

Endothelial dysfunction in patients with ankylosing spondylitis [10.5114/reum.2019.84815]


The Acarbose Cardiovascular Evaluation (ACE) trial formally evaluated whether acarbose could reduce the frequency of cardiovascular events in patients with established coronary heart disease and impaired glucose tolerance, and whether the incidence of Type 2 diabetes could be reduced.

Effect of acarbose on cardiovascular events and new-onset diabetes in patients with coronary heart disease and impaired glucose tolerance. [10.2217/fca-2018-0062]


Smoking is a well-established risk factor for coronary artery calcium (CAC) and adverse cardiovascular outcomes, yet smoking has been associated with reduced serum.

Gout Is Associated With Increased Coronary Artery Calcification and Adverse Cardiovascular Outcomes. [10.1016/j.jcmg.2019.10.019]


While cholesterol content in high-density lipoproteins (HDLs) is a well-established inverse marker of cardiovascular risk, the importance of HDL–triglyceride (HDL-TG) concentration is not well known.

HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk [10.3390/ijms20133151]


Highly Related Keywords from Cardiovascular

Research Hotspot

Circulation. Cardiovascular quality and outcomes

Research Hotspot
Circulation. Cardiovascular quality and outcomes Related Journals

Popular Journals